GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Magnasense AB (FRA:52Q) » Definitions » Capex-to-Operating-Income

Magnasense AB (FRA:52Q) Capex-to-Operating-Income : 0.00 (As of Dec. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Magnasense AB Capex-to-Operating-Income?

Capex-to-Operating-Income measures a company's investments in physical assets such as property, industrial buildings or equipment to its operating income.

Magnasense AB's Capital Expenditure for the three months ended in Dec. 2024 was €-0.11 Mil. Its Operating Income for the three months ended in Dec. 2024 was €-1.83 Mil.

GuruFocus do not calculate Capex-to-Operating-Income if the Operating Income is negative.


Magnasense AB Capex-to-Operating-Income Historical Data

The historical data trend for Magnasense AB's Capex-to-Operating-Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Magnasense AB Capex-to-Operating-Income Chart

Magnasense AB Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Capex-to-Operating-Income
Get a 7-Day Free Trial - - - - -

Magnasense AB Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Capex-to-Operating-Income Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Magnasense AB's Capex-to-Operating-Income

For the Medical Devices subindustry, Magnasense AB's Capex-to-Operating-Income, along with its competitors' market caps and Capex-to-Operating-Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Magnasense AB's Capex-to-Operating-Income Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Magnasense AB's Capex-to-Operating-Income distribution charts can be found below:

* The bar in red indicates where Magnasense AB's Capex-to-Operating-Income falls into.


;
;

Magnasense AB Capex-to-Operating-Income Calculation

Magnasense AB's Capex-to-Operating-Income for the fiscal year that ended in Dec. 2024 is calculated as

Capex-to-Operating-Income=- Capital Expenditure / Operating Income
=- (-1.352) / -4.075
=N/A

Magnasense AB's Capex-to-Operating-Income for the quarter that ended in Dec. 2024 is calculated as

Capex-to-Operating-Income=- Capital Expenditure / Operating Income
=- (-0.11) / -1.826
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Magnasense AB  (FRA:52Q) Capex-to-Operating-Income Explanation

Capex-to-Operating-Income assesses how much emphasis a company is placing upon investing in capital-intensive projects. The ratio is generally a good gauge to quantify how much focus on growth a company has. Typically, smaller companies that are still growing and expanding will have a higher Capex to Operating Income Ratio, since such businesses are likely investing more in physical assets. Lower ratios could indicate that a company has reached maturity and it is no longer pursuing aggressive growth.


Magnasense AB Capex-to-Operating-Income Related Terms

Thank you for viewing the detailed overview of Magnasense AB's Capex-to-Operating-Income provided by GuruFocus.com. Please click on the following links to see related term pages.


Magnasense AB Business Description

Traded in Other Exchanges
Address
Scheelevagen 27, Lund, SWE, SE-223 63
AegirBio AB is a Swedish diagnostic company, specializes in developing a home testing platform for oral health, therapeutic drug monitoring and infectious diseases. The current product line up includes the Veritope technology, featuring intact natalizumab in MS, along with the MagniaReader designed for both research and veterinary applications.

Magnasense AB Headlines

No Headlines